Clin Podiatr Med Surg. 1996 Jan;13(1):13-29.


The prevalence and clinical types of onychomycosis and diagnostic methods are reviewed in this article. The need for correct identification of the causative organism is emphasized. The use of oral and topical therapeutic agents is outlined, with specific emphasis on relevant research data and potential side effects of these agents. Sections on the potential hazard of nail dust, onychomycosis in HIV-infected patients, and the long-term management of onychomycosis are also included.

Publication types

  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / microbiology
  • Administration, Cutaneous
  • Administration, Oral
  • Adolescent
  • Adult
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use
  • Diagnosis, Differential
  • Dust
  • Humans
  • Middle Aged
  • Occupational Exposure
  • Onychomycosis / diagnosis*
  • Onychomycosis / drug therapy
  • Onychomycosis / microbiology


  • Antifungal Agents
  • Dust